Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2008 Jun 21.

Published in final edited form as: Schizophr Res. 2007 Feb 21;92(1-3):278–279. doi: 10.1016/j.schres.2006.12.019

Table 1.

Distribution of mean AIMS score according to genotype in patients with TD.

Polymorphism^#	AIMS score (mean±SD)			p-value^*
Polymorphism^#	11	12	22	p-value^*
SOD2 Ala9Val C/T	7.12±4.16	6.17±3.29	5.67±2.89	0.436
UCP2 45bp del/ins	6.35±3.21	5.93±3.70	--	0.287
NOS1 rs1047735 C/T	6.12±3.43	5.76±2.96	7.00±3.63	0.730
NOS1 rs2682826 C/T	5.84±3.24	6.03±3.40	7.17±3.43	0.591
NOS3 27bp ins/dup	6.81±3.63	5.13±3.20	7.50±2.12	0.038
GSTM1 Presence/Null	6.00±3.29		6.33±3.46	0.643
GSTT1 Presence/Null	6.27±5.27		5.27±2.28	0.580
GSTPI Ile105Val A/G	5.68±2.57	6.49±3.63	6.11±4.51	0.595
NQO1 Pro187Ser C/T	6.20±3.40	6.80±3.40	3.57±0.54	0.061^ψ

^#

The 11 genotype corresponds to the first allele e.g. Ala9Val C/T 11=CC, 12=CT,22=TT genotypes;

^*

Kruksal Wallis H test;

^ψ

CC+CT vs TT 6.42 ± 3.44 vs. 3.57 ± 0.54; p=0.025